Navin Fluorine shares at 52-week high after 10% jump; UBS gives it its highest price target

Navin Fluorine’s revenue was in-line with estimates, while its net profit and EBITDA margin exceeded estimates for the quarter. The management said that they expect strong growth in the CDMO business in FY26.